Correlation Between Astellas Pharma and Salesforce
Can any of the company-specific risk be diversified away by investing in both Astellas Pharma and Salesforce at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Astellas Pharma and Salesforce into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Astellas Pharma and Salesforce, you can compare the effects of market volatilities on Astellas Pharma and Salesforce and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Astellas Pharma with a short position of Salesforce. Check out your portfolio center. Please also check ongoing floating volatility patterns of Astellas Pharma and Salesforce.
Diversification Opportunities for Astellas Pharma and Salesforce
-0.84 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Astellas and Salesforce is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Astellas Pharma and Salesforce in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Salesforce and Astellas Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Astellas Pharma are associated (or correlated) with Salesforce. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Salesforce has no effect on the direction of Astellas Pharma i.e., Astellas Pharma and Salesforce go up and down completely randomly.
Pair Corralation between Astellas Pharma and Salesforce
Assuming the 90 days horizon Astellas Pharma is expected to under-perform the Salesforce. But the stock apears to be less risky and, when comparing its historical volatility, Astellas Pharma is 1.68 times less risky than Salesforce. The stock trades about -0.11 of its potential returns per unit of risk. The Salesforce is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 32,505 in Salesforce on September 13, 2024 and sell it today you would earn a total of 1,540 from holding Salesforce or generate 4.74% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Astellas Pharma vs. Salesforce
Performance |
| Timeline |
| Astellas Pharma |
| Salesforce |
Astellas Pharma and Salesforce Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Astellas Pharma and Salesforce
The main advantage of trading using opposite Astellas Pharma and Salesforce positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Astellas Pharma position performs unexpectedly, Salesforce can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Salesforce will offset losses from the drop in Salesforce's long position.| Astellas Pharma vs. WIMFARM SA EO | Astellas Pharma vs. Dairy Farm International | Astellas Pharma vs. TITAN MACHINERY | Astellas Pharma vs. AGRICULTBK HADR25 YC |
| Salesforce vs. Superior Plus Corp | Salesforce vs. SIVERS SEMICONDUCTORS AB | Salesforce vs. Norsk Hydro ASA | Salesforce vs. Reliance Steel Aluminum |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |